Triton Market Research has concluded that the North America immunosuppressant drugs market will grow at a CAGR of 3.03% in the estimated years 2019-2028.
The countries analyzed in this market include:
• The United States
• Canada
In Canada, approx. 2 million people are affected by autoimmune diseases. Around 50 types of known autoimmune diseases are said to affect around two million Canadians. Furthermore, according to the Arthritis Society, around 1 in 100 persons in the country is reported to have rheumatoid arthritis. Though, it mostly affects the middle-aged, it can also affect younger older people. Canada also has one of the highest rates of multiple sclerosis in the world. This condition is more prevalent in women.
Sjögren's syndrome is also one of the commonly occurring diseases in the country, and an estimated 430,000 people are said to live with the disease. Immunosuppressant drugs form a crucial part of the treatment for autoimmune disorders. Hence, the rising prevalence of autoimmune disorders in the country calls for an increasing adoption of immunosuppressant drugs. This is supporting the growth of the Canadian immunosuppressant drugs market.
Organ transplantation also significantly takes place in the nation. A total of 2,782 organ transplants were performed in 2018, according to the Canadian Organ Replacement Register (CORR). As per the data, out of the 762 deceased donors in the year, 71% were cases of donation after brain death (NDD), and 29% were cases of donation after cardio-circulatory death (DCD). There was an increase of 21% in NDD and an increase of 429% in DCD over a ten-year period in 2018. Immunosuppressant drugs are widely used to treat patients during these transplantation procedures. This is aiding the growth of the immunosuppressant drugs market in Canada over the forecasting period.
AbbVie Inc is a research-based biopharmaceutical company, which discovers, develops, manufactures, and sells a range of pharmaceutical products. The company's products are focused on treating chronic autoimmune diseases, among other serious health conditions. RINVOQ, HUMIRA, Upadacitinib, and Risankizumab are some of the immunosuppressant drugs it produces. The US-based company is headquartered in North Chicago, Illinois.
The top key players in the immunosuppressant drugs market are Pfizer Inc, Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc), Veloxis Pharmaceuticals Inc, Intas Pharmaceuticals Ltd (Accord Healthcare), Dr Reddys Laboratories Ltd, Cipla Ltd, GlaxoSmithKline plc, F Hoffmann-La Roche Ltd, Mylan NV, Novartis AG, Astellas Pharma Inc, Allergan (acquired by Abbvie Inc), Abbvie Inc, Bristol-Myers Squibb Company, and Sanofi.